Cargando…

Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine

Detalles Bibliográficos
Autores principales: Karlsson-Parra, Alex, Laurell, Anna, Lönnemark, Maria, Brekkan, Einar, Wallgren, AnnaCarin, Magnusson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652473/
http://dx.doi.org/10.1186/2051-1426-3-S2-P438
_version_ 1782401761602961408
author Karlsson-Parra, Alex
Laurell, Anna
Lönnemark, Maria
Brekkan, Einar
Wallgren, AnnaCarin
Magnusson, Anders
author_facet Karlsson-Parra, Alex
Laurell, Anna
Lönnemark, Maria
Brekkan, Einar
Wallgren, AnnaCarin
Magnusson, Anders
author_sort Karlsson-Parra, Alex
collection PubMed
description
format Online
Article
Text
id pubmed-4652473
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46524732015-11-25 Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine Karlsson-Parra, Alex Laurell, Anna Lönnemark, Maria Brekkan, Einar Wallgren, AnnaCarin Magnusson, Anders J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652473/ http://dx.doi.org/10.1186/2051-1426-3-S2-P438 Text en Copyright © 2015 Karlsson-Parra et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Karlsson-Parra, Alex
Laurell, Anna
Lönnemark, Maria
Brekkan, Einar
Wallgren, AnnaCarin
Magnusson, Anders
Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title_full Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title_fullStr Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title_full_unstemmed Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title_short Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
title_sort long-term survival in unfavourable-risk mrcc patients after intratumoral administration of a cell-based allogeneic vaccine
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652473/
http://dx.doi.org/10.1186/2051-1426-3-S2-P438
work_keys_str_mv AT karlssonparraalex longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine
AT laurellanna longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine
AT lonnemarkmaria longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine
AT brekkaneinar longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine
AT wallgrenannacarin longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine
AT magnussonanders longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine